2015•International Journal of Clinical PharmacyRequires access

Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa

Jesús Cotrina Luque, María Victoria Gil-Navarro, Héctor Acosta-García, Eva Rocío Alfaro‐Lara, Rafael Luque‐Márquez, Margarita Beltrán-García, Francisco Javier Bautista Paloma

Open publisher page 27 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 27 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Piperacillin/tazobactam, Tazobactam, Piperacillin, Adverse effect, Randomized controlled trial, Anesthesia, Clinical trial

Back to paper search Browse research topics Original source

Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa — Research Paper | ScholarLens